TD Private Client Wealth’s CONMED CNMD Stock Holding History

TD Private Client Wealth’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-18	Closed	-$1.44K	–	1221
2022 Q3	$1.44K	Sell	18 -2	-10%	-$189	﹤0.01%	1137
2022 Q2	$1.92K	Hold	20	–	–	﹤0.01%	1133
2022 Q1	$2.97K	Hold	20	–	–	﹤0.01%	1133
2021 Q4	$2.83K	Hold	20	–	–	﹤0.01%	991
2021 Q3	$2.62K	Hold	20	–	–	﹤0.01%	1011
2021 Q2	$2.75K	Buy	+20	New	+$2.74K	﹤0.01%	1012

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

TD Private Client Wealth's CNMD Position: Q4 2022 in Review

TD Private Client Wealth sold out of CONMED (CNMD) in Q4 2022, closing a stake of 18 shares — an estimated $1.44K sold.

TD Private Client Wealth first reported a position in CNMD in Q2 2021 and held it in 6 quarters. The position peaked at $2.97K in Q1 2022. 239 funds tracked by Wall St. Rank hold CNMD as of Q4 2022.

TD Private Client Wealth reported no remaining CONMED position as of Q4 2022 after selling out during the quarter.
TD Private Client Wealth sold 18 CONMED shares in Q4 2022, an estimated $1.44K.
TD Private Client Wealth first reported a position in CONMED in Q2 2021 and held it in 6 quarters.
TD Private Client Wealth's CONMED position peaked at $2.97K in Q1 2022.
239 funds tracked by Wall St. Rank held CONMED as of Q4 2022.

Based on TD Private Client Wealth's 13F filing for Q4 2022, filed 16 Aug 2024.